The opening follows shortly after MolGen opened its US office in San Diego
Anthony Haynes, Managing Director and Greig Pollard, Head of Automation UK
MolGen, a global solutions provider of DNA / RNA extraction technology, has recently opened a UK office in London. The expansion is hoped to enable the company to meet increasing demand for diagnostic service, while the location will serve as a pivotal branch to provide laboratories in London and the UK access to the company’s DNA / RNA portfolio across diagnostics, pharma and the biotech industry. The opening follows shortly after MolGen opened its US office in San Diego.
“We have been fortunate to experience such rapid growth as a company. Our ability to scale quickly has been a great asset as we continue to strive to meet the growing demand for our innovations. We see this new office as a way to further advance the testing and diagnostics industry and provide solutions as to how the world responds to disease and other life science conditions,” said Niels Kruize, MolGen CCO.
The UK office will serve as the launch point for the company’s MegaPrep product, which the company describes as a a bi-weekly, non-invasive monitoring PCR test that gives users the ability to analyse up to a million samples a day. Using more devices that can be customised to each lab, the product is designed to bring precision, speed and quality to the diagnostics workflow, resulting in accurate analysis at scale. It’s also operated on a pay-by-sample basis, which the company says will help more parts of society, such as schools and business to remain open and combat disease.